Status:

RECRUITING

Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer

Lead Sponsor:

Mayo Clinic

Conditions:

Rectal Carcinoma

Eligibility:

All Genders

18-99 years

Brief Summary

This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better than, MRI for the management of patients ...

Eligibility Criteria

Inclusion

  • Adult patients 18 to 99 years of age
  • Patients with proven rectal cancer clinically referred for staging pelvic MRI and contrast-enhanced CT of the abdomen and pelvis (for evaluation of liver and peritoneal disease)
  • Endoscopic or imaging report that tumor is 2 cm or larger
  • Patients who are able and willing to sign the informed consent
  • Negative pregnancy test if subject is of child-bearing age (females of child-bearing potential will be screened for pregnancy using a urine pregnancy test, which will be administered by the unit study coordinator at no cost to the patient)

Exclusion

  • Minors less than 18 years old
  • Known mucinous adenocarcinoma (may not enhance well)
  • Patient unable to provide written informed consent
  • Pregnancy
  • estimated Glomerular Filtration Rate (eGFR) ≤ 60
  • History of prior moderate or severe contrast reaction including unresponsiveness, severe respiratory distress, convulsions, arrhythmia, cardiopulmonary distress, progressive angioedema, laryngeal edema, dyspnea, bronchospasm, symptomatic tachycardia, symptomatic bradycardia, hypotension, hypertensive crisis
  • Any history of premedication prior to iodinated contrast
  • Hip replacement/prosthesis
  • Patients that consent to participation but do not undergo their clinically indicated MRI scanning for any reason (e.g., bad IV, infiltration, reaction, change in indication)

Key Trial Info

Start Date :

October 7 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06965166

Start Date

October 7 2024

End Date

December 31 2026

Last Update

October 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905